R2 Technologies
R2 Technologies, headquartered in Silicon Valley and founded in 2014, develops CryoAesthetics® treatments like Glacial® Rx, which uses precision cooling to reduce inflammation and improve skin conditions.
Company History
R2 Technologies was founded in 2014 by Pansend Life Sciences, LLC, Blossom Innovations, LLC, and Massachusetts General Hospital. The company is headquartered in Silicon Valley. In 2019, R2 Technologies entered into a strategic partnership with Huadong Medicine Co., Ltd., which has further enabled their growth and development. R2 Technologies focuses on leveraging proprietary precision cooling technology to develop innovative CryoAesthetics® treatments.
Glacial® Rx: CryoAesthetics® Treatment
Glacial® Rx by R2 Technologies is the first and only CryoAesthetics® treatment that uses precision cooling to address inflammation and enhance skin from within. This FDA-cleared treatment is clinically proven and customizable, offering three different modalities. Indicated for the reduction of pain, inflammation, and swelling, Glacial® Rx also targets the removal of benign lesions and can be used with dermabrasion tips for general dermabrasion. Clinical studies have validated its safety, showing no device-related serious adverse events in over 600 patients.
Cryomodulation Technology
Cryomodulation is R2 Technologies' proprietary precision cooling technology. It calms inflammation, brightens skin, and treats benign lesions by delivering cooling at the optimal temperature and duration based on each patient’s unique biology. This technology enhances the appearance of skin conditions such as redness and inflammation and is cleared for use in reducing pain, inflammation, and thermal injury during dermatological treatments.
Strategic Partnerships and Community Involvement
R2 Technologies has a strategic partnership with Huadong Medicine Co., Ltd. since 2019. The company is also committed to global charitable activities, partnering with organizations to improve outcomes for underserved sufferers of skin diseases and conditions. These initiatives demonstrate R2 Technologies' dedication to leveraging its innovations for broader community benefits.
Product Offerings
R2 Technologies has developed several products, including Glacial® Rx, Glacial® fx, and Glacial® Spa. These products are powered by intellectual property licensed from Massachusetts General Hospital. The company’s offerings are designed to work either as standalone treatments or in combination with other heat- or light-based therapies, providing flexible solutions for various skin conditions and aesthetic needs.